You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Protocol for a randomised, open-label, parallel group, multicentre controlled study to evaluate the clinical performance and safety of Stay Safe Link compared with Stay Safe in patients with end-stage kidney disease on continuous ambulatory peritoneal di…

Article metrics

Article menu

Download PDFPDF

XML
Renal medicine
Protocol
Protocol for a randomised, open-label, parallel group, multicentre controlled study to evaluate the clinical performance and safety of Stay Safe Link compared with Stay Safe in patients with end-stage kidney disease on continuous ambulatory peritoneal dialysis

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 201982482085
Apr 2019969419
May 2019787424
Jun 2019645910
Jul 201954529
Aug 201925223
Oct 2019303030
Nov 2019232210
Dec 2019201616
Jan 2020282710
Feb 202023237
Mar 202019188
May 202032329
Jun 202026238
Jul 2020558
Aug 20201294
Sep 202014121
Oct 2020252413
Nov 202012127
Dec 2020171612
Jan 2021312812
Feb 2021665
Mar 202116169
Apr 2021191812
May 202112127
Jun 2021222210
Jul 2021423720
Aug 2021556
Sep 202122189
Oct 2021202029
Nov 2021131217
Dec 202114138
Jan 202211107
Feb 202291111
Mar 202220228
Apr 2022151513
May 2022151515
Jun 2022151520
Jul 20221175
Aug 202213109
Sep 20227720
Oct 2022141110
Nov 20228710
Dec 2022442
Jan 2023442
Feb 202313128
Mar 2023552
Apr 2023731
May 202310105
Jun 2023552
Jul 202319186
Aug 202314148
Sep 2023775
Oct 2023772
Nov 202311101
Dec 2023232410
Jan 2024301712
Feb 202421106
Mar 202419126
Apr 2024994
Total19951898647